Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Renee P. Tannenbaum files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nikhil Lalwani - $5.05M in ANIP purchases and sales in the last 12 months
- Patrick D. Walsh - $2.32M in ANIP purchases and sales in the last 12 months
- Stephen P. Carey - $1.99M in ANIP purchases and sales in the last 12 months
- Christopher Mutz - $1.64M in ANIP purchases and sales in the last 12 months
- Chad Gassert - $1.31M in ANIP purchases and sales in the last 12 months
- Gary W. Pace - $1.04M in CRDF purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Renee P. Tannenbaum?
Renee P. Tannenbaum is a corporate insider of Cardiff Oncology, Inc. (CRDF). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Renee P. Tannenbaum last file a Form 4?
The most recent primary Form 4 on record is dated 16 June 2026, one of 5 filings going back to 2024.
Has Renee P. Tannenbaum been buying or selling stock?
Recorded transactions: 1 open-market purchase ($34K) and 0 open-market sales across all tracked filings.
